Research Update: Ingenovis Health Inc. Ratings Lowered To 'B-' From 'B' on Weaker Operating Performance, Outlook Stable - S&P Global Ratings’ Credit Research

Research Update: Ingenovis Health Inc. Ratings Lowered To 'B-' From 'B' on Weaker Operating Performance, Outlook Stable

Research Update: Ingenovis Health Inc. Ratings Lowered To 'B-' From 'B' on Weaker Operating Performance, Outlook Stable - S&P Global Ratings’ Credit Research
Research Update: Ingenovis Health Inc. Ratings Lowered To 'B-' From 'B' on Weaker Operating Performance, Outlook Stable
Published Jul 12, 2024
8 pages (3156 words) — Published Jul 12, 2024
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

Healthcare staffing company Ingenovis Health Inc., along with industry peers, is experiencing a steep decline in demand for travel nurses and a lower bill-pay spread, as hospitals seek to use more permanent staff and fewer temporary staff than in the past. That said, we believe financial performance will begin to gradually improve in the second half of 2024, helped by rising demand, cost-cutting initiatives, and a gradual decline in wages for travel nurses that will improve the bill-pay spread. Following a sharp rise in S&P Global Ratings-adjusted leverage in 2023 to about 9x, we expect leverage to rise to about 15x in 2024, before improving in 2025, and that the company will generate modest free cash flow in 2024 and

  
Brief Excerpt:

...- Healthcare staffing company Ingenovis Health Inc., along with industry peers, is experiencing a steep decline in demand for travel nurses and a lower bill-pay spread, as hospitals seek to use more permanent staff and fewer temporary staff than in the past. - That said, we believe financial performance will begin to gradually improve in the second half of 2024, helped by rising demand, cost-cutting initiatives, and a gradual decline in wages for travel nurses that will improve the bill-pay spread. - Following a sharp rise in S&P Global Ratings-adjusted leverage in 2023 to about 9x, we expect leverage to rise to about 15x in 2024, before improving in 2025, and that the company will generate modest free cash flow in 2024 and 2025, supported by a reduction in working capital. - We lowered our issuer credit rating and issue-level ratings on Ingenovis to 'B-' from 'B'. The '3' recovery rating on its revolving credit facility and first-lien term loan is unchanged. - The stable outlook reflects...

  
Report Type:

Research Update

Ticker
1945875D
Issuer
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: Ingenovis Health Inc. Ratings Lowered To 'B-' From 'B' on Weaker Operating Performance, Outlook Stable" Jul 12, 2024. Alacra Store. May 21, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Ingenovis-Health-Inc-Ratings-Lowered-To-B-From-B-on-Weaker-Operating-Performance-Outlook-Stable-3213796>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: Ingenovis Health Inc. Ratings Lowered To 'B-' From 'B' on Weaker Operating Performance, Outlook Stable Jul 12, 2024. New York, NY: Alacra Store. Retrieved May 21, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-Ingenovis-Health-Inc-Ratings-Lowered-To-B-From-B-on-Weaker-Operating-Performance-Outlook-Stable-3213796>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.